* TOTAL : 14,798 건
- Safety Outcomes Of Finerenone In Asian Patients With Type 2 Diabetes And Chronic Kidney Disease: A FIDELITY Analysis
-
Satoshi Yamashita2024 ; 2024(1):
- 초록보기 PDF 원문보기
- Safety, Tolerability, and Pharmacodynamics of ARO-C3, a Subcutaneously Administered Investigational RNA-interference Therapeutic Targeting Complement C3 in Adult Healthy Volunteers: Interim Findings from the AROC3-1001 Study
-
Nick Cross2024 ; 2024(1):
- 초록보기 PDF 원문보기
- Efficacy of Denosumab for Osteoporosis in Hemodialysis Patients
-
Ji Hwan Kim2024 ; 2024(1):
- 초록보기 PDF 원문보기
- A Lupus Nephritis Patient with Negative ANA and anti-dsDNA
-
Darryl Virgiawan Tanod2024 ; 2024(1):
- 초록보기 PDF 원문보기
- Comparative study of changes in the vital signs during surgery under general anesthesia in hemodialysis patients
-
Nakashima Takahiro2024 ; 2024(1):
- 초록보기 PDF 원문보기
- Safety and Efficacy of Belimumab in Patients with Lupus Nephritis: A Systematic Review and Meta-Analysis
-
Tohari Tohari2024 ; 2024(1):
- 초록보기 PDF 원문보기
- The cumulative detrimental effect of intradialytic hypotension on kidney recovery in patients with acute kidney injury receiving intermittent hemodialysis
-
Joon hee Yoon2024 ; 2024(1):
- 초록보기 PDF 원문보기
- Developing an AI-powered prescription algorithm for maintenance hemodialysis patients
-
Gwangeon Sim2024 ; 2024(1):
- 초록보기 PDF 원문보기
- Establishment of a rapidly progressing ADPKD model and verification of the effect of an AMPK activator (HL156A)
-
Hyunsuk Kim2024 ; 2024(1):
- 초록보기 PDF 원문보기
(06022) 서울시 강남구 압구정로 30길 23 미승빌딩 301호
- Tel: 02)3486-8736
- Fax: 02)3486-8737
- E-mail: ksn@ksn.or.kr
- 사업자 등록번호: 208-82-60817
- 대표자: 최범순
Copyright© 대한신장학회. All rights reserved.
